ANI Pharmaceuticals, Inc. (ANIP) operating margin

Operating margin · fiscal 2025
9.2%

ANI Pharmaceuticals, Inc. (ANIP) had an operating margin of 9.2% in fiscal 2025 (the year ended December 31, 2025). That is 8.8 percentage points higher than the 0.4% of fiscal 2024. Figures as of 17 Nov 2026, 19:15 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Operating margin, fiscal 2025
9.2%
Change on fiscal 2024
+8.8 pts
Highest on record
42.8%fiscal 2015
Lowest on record
-18.4%fiscal 2021
Fiscal years on record
142012–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

ANI Pharmaceuticals, Inc. operating margin, in more detail

Across the 14 fiscal years on record (2012–2025), the highest was 42.8% in fiscal 2015 and the lowest -18.4% in fiscal 2021. The fiscal 2025 figure is higher than in 54% of the 13 earlier fiscal years on record, whose median is 7.9%.

Gross margin was 61.4% in fiscal 2025. Net margin was 8.9% in fiscal 2025.

History · 14 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Gross margin
  • Net margin

ANI Pharmaceuticals, Inc. operating margin, year by year

ANI Pharmaceuticals, Inc. (ANIP) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedGross marginNet margin
20259.2% 8.8 pts up61.4%8.9%
20240.4% 9.8 pts down59.3%-3.0%
202310.2% 18.3 pts up62.7%3.9%
2022-8.1% 10.3 pts up56.1%-15.1%
2021-18.4% 10.7 pts down—-19.7%
2020-7.7% 15.6 pts down—-10.8%
20197.9% 9.6 pts down—3.0%
201817.5% 1.5 pts up—7.7%
201716.0% 0.4 pts up—-0.6%
201615.6% 27.2 pts down—3.1%
201542.8% 7.1 pts up—20.1%
201435.7% 32.8 pts up—51.4%
20133.0% 3.2 pts up—1.0%
2012-0.2%——-7.4%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

More on ANIP

ANI Pharmaceuticals, Inc., figure by figure

ANI Pharmaceuticals, Inc. (ANIP) overview: price, valuation and scorecard

ANI Pharmaceuticals, Inc. operating margin: questions and answers

What is ANI Pharmaceuticals, Inc.'s operating margin?

ANI Pharmaceuticals, Inc. (ANIP) had an operating margin of 9.2% in fiscal 2025 (the year ended December 31, 2025). That is 8.8 percentage points higher than the 0.4% of fiscal 2024.

Is ANI Pharmaceuticals, Inc.'s operating margin high or low compared with its own history?

The fiscal 2025 figure is higher than in 54% of the 13 earlier fiscal years on record, whose median is 7.9%.

What are the highest and lowest operating margin figures on record for ANI Pharmaceuticals, Inc.?

Across the 14 fiscal years on record (2012–2025), the highest was 42.8% in fiscal 2015 and the lowest -18.4% in fiscal 2021.

What are ANI Pharmaceuticals, Inc.'s gross and net margins?

Gross margin was 61.4% in fiscal 2025. Net margin was 8.9% in fiscal 2025.

How is ANI Pharmaceuticals, Inc.'s operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ANI Pharmaceuticals, Inc. (ANIP) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/ANIP/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.